Overall, our systemic cytokine data fromtumour-bearing mice treated with or without STING agonist in the presence or absenceof CD8+ T cells shows that the effect of STING agonisttreatment is not restricted to the localised tumour microenvironment. The gene discussed is STING1; the disease is neoplasm.